These findings suggest potential for GLP-1 RAs to help mitigate SUD in these populations
If you have cardiovascular risk factors such as high blood pressure, high cholesterol, or a history of heart disease, your healthcare provider may consider GLP-1 shots as part of your treatment plan to help reduce your risk of cardiovascular complications
Weight Loss Semaglutide: is a revolutionary GLP-1 receptor agonists that were originally developed for patients with Type 2 diabetes, but when providers and pharmaceutical developers noticed how much weight their patients were losing, they began to study GLP-1 medications exclusively for weight loss
The study found a statistically significant number of patients achieved weight loss with combination treatment as compared to placebo
It has generated impressive preclinical data in rodent models of tissue repair
Patients need to focus on the underlying issues of weight gain if they do not want to continuously take Ozempic